UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 31, 2021 4:00 P.M.
Form:
F-3
CIK:
0001722926
Company Name:
ASLAN Pharmaceuticals Ltd
File Number:
333-254768